Lucira Health to Participate in William Blair 41st Annual Growth Stock Conference

NEXT STORY
Sean Lavin, MD, Joins Progenity as Vice President, Business Development, Strategy, and Investor Relations
PREV STORY
Intranasal Drug and Vaccine Market 2028 – Insights on Key Trends, COVID-19 Impact, Value Chain Analysis, Strategic Initiatives, and Future Outlook: Adroit Market Research
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Heat Biologics Presents New Preclinical Data from OncoSec Collaboration at the American Association for Cancer Research (AACR) Annual Meeting

Combining ComPACT DNA electroporation and cellular vaccination led to increased tumor antigen-specific CD8+ T ...

author_avatar
NASDAQ Market News

Cyclacel Pharmaceuticals to Present at the 2018 BIO CEO & Investor Conference

BERKELEY HEIGHTS, N.J., Feb. 06, 2018 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) (NASDAQ:CYCCP) ...

author_avatar
NASDAQ Market News

Shire plc : CHMP RECOMMENDS EU MARKETING AUTHORIZATION FOR VEYVONDI(R) FOR ADULTS WITH VON WILLEBRAND DISEASE

CHMP RECOMMENDS EU MARKETING AUTHORIZATION FOR VEYVONDI® [VONICOG ALFA, RECOMBINANT VON WILLEBRAND FACTOR] FOR ...

author_avatar
NASDAQ Market News